PedAM
Pediatric Disease Annotations & Medicines
| Disease | pulmonary hypertension |
| Phenotype | C0018799|cardiac disease |
| Sentences | 4 |
| PubMedID- 23293388 | [15] inhaled nitric oxide, prostacyclin analogues and phosphodiesterase inhibitors play a key role in controlling pulmonary hypertension associated with various congenital cardiac diseases. |
| PubMedID- 21144100 | We studied the correlation between the glu298asp polymorphism of the endothelial nitric oxide synthase gene and pulmonary hypertension in children with congenital cardiac diseases. |
| PubMedID- 25146706 | Conclusions: in this study, doppler echocardiography proved to be a reliable method for the assessment of spap, being well suited to establish the noninvasive diagnosis of pulmonary hypertension in patients with cardiac diseases. |
| PubMedID- 20352134 | They have distinctive forms of heart failure, and their cardiac disease can be associated with pulmonary hypertension, thromboemboli, complex arrhythmias and sudden death.medical aspects that need to be considered relate to the long-term and multisystemic effects of single-ventricle physiology, cyanosis, systemic right ventricles, complex intracardiac baffles and failing subpulmonary right ventricles. |
Page: 1